FOLEY TRASIMENE ACQUISITION's ticker is BFT and the CUSIP is 344328109. A total of 1 filers reported holding FOLEY TRASIMENE ACQUISITION in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alua Capital Management LP | 3,125,000 | $47,188,000 | 3.30% |
| Tiger Eye Capital LLC | 1,067,068 | $16,113,000 | 3.21% |
| BLOOM TREE PARTNERS, LLC | 2,725,821 | $41,160,000 | 2.86% |
| Ratan Capital Management LP | 1,559,998 | $23,556,000 | 2.75% |
| Yarra Square Partners LP | 175,000 | $2,643,000 | 2.28% |
| Stieven Capital Advisors, L.P. | 927,257 | $14,002,000 | 2.24% |
| DSAM Partners (London) Ltd | 1,157,829 | $17,483,000 | 2.05% |
| JCSD Capital, LLC | 101,000 | $1,525,000 | 1.71% |
| Alight Capital Management LP | 500,000 | $7,550,000 | 1.71% |
| Cheyne Capital Management (UK) LLP | 201,500 | $3,043,000 | 1.54% |